UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2022
Commission File Number: 001-39633
Abcam plc
(Translation of registrant’s name into English)
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On March 17, 2022, Abcam plc (the “Company”) issued a regulatory news service announcement (the “Announcement”), as required by the laws and regulations of the United Kingdom, announcing the acquisition of shares by its Chief Executive Officer and by its Chief Financial Officer. The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Regulatory News Service Announcement dated March 17, 2022 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ABCAM PLC | ||||||
Date: March 17, 2022 | By: | /s/ Alan Hirzel | ||||
Name: | Alan Hirzel | |||||
Title: | Chief Executive Officer |